Abstract:AIM:To examine the effect of celecoxib on tumor growth and angiogenesis in an orthotopic implantation tumor model of colon cancer.METHODS:Human colorectal adenocarcinoma HT-29 cells were implanted subcutaneously in nude mice. Four groups of animals received different doses of celecoxib after tumor implantation. After 42 days, all animals were evaluated for changes in body weight, the volume and weight of colorectal tumors, and tumor growth inhibition. The content of prostaglandin E(2) (PGE(2)) in the tumor tissue homogenate was estimated by radioimmunoassay (RIA). Cyclooxygenase-2 (COX-2) and CD34 expression in tumor tissue was assessed by immunohistochemistry, and the microvessel density (MVD) of tumor tissue was determined. Apoptosis of the tumor cells was detected by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL). The expression of vascular endothelial growth factor (VEGF) mRNA and matrix metalloproteinase-2 (MMP-2) mRNA extracted from the tumor tissue was analyzed by reverse transcriptase polymerase chain reaction (RT-PCR).RESULTS:There was no statistically significant change in the animals' body weight between the treatment groups. However, with increasing doses of celecoxib, the volume and weight of the tumor decreased. The rates of tumor growth inhibition for the L (low), M (medium) and H (high) groups were 25.30%, 38.80%, and 76.92%, respectively, which were significant compared to the C (control) group. There were significant differences in COX-2 expression in the tumor tissue between all groups, except between the L and M groups. Celecoxib exposure also reduced PGE2 levels in the tumor tissue homogenates. The level of PGE(2) correlated to the weight of tumor (r=0.8814, P < 0.05) and to COX-2 expression (r=0.8249, Puse < 0.05). Compared to the control group, the tumor cells from celecoxib-treated mice had a significantly higher apoptotic index. Celecoxib also decreased CD34(+) expression in tumors from treated mice. There were significant differences in the MVD between all groups except between groups H and M. Celecoxib significantly reduced the expression of VEGF and MMP-2 mRNA in the group H but not in L and M groups. The MVD in tumor tissue was closely related to the PGE2 levels, as well as the expression of VEGF and MMP-2 mRNA (r = 0.9006, r = 0.8573 and r = 0.6427, respectively; P < 0.05).CONCLUSIONS:By inhibiting COX-2, PGE(2) synthesis, and VEGF and MMP-2 mRNA expression in tumor tissue, celecoxib enhances tumor cell apoptosis, thereby inhibiting the growth and angiogenesis of orthotopically implanted tumors in a mouse model of human colorectal cancer.

Efficacy of Celebrex in inhibition of breast cancer bone metastasis on a nude mouse model

Experimental Study of the Therapeutic Effectiveness and Mechanism of Bispecific HER2 × CD3 Antibodies to HER2-overexpressing Xenografts in Nude Mice

Impact of the Selective Cyclooxygenase-2 Inhibitor Celebrex on Angiogenesis in Pancreatic Carcinoma

[Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF) in Pancreatic Carcinoma].

Effect of celecoxib on hepatic and renal functions in rats with mammary carcinoma

Celecoxib in the Histological Grade of Chemically Induced Mammary Tumor in Rats

Study on the Therapeutic Efficacy of Subcutaneous Colon Cancer Xenograft Tumor with Ultrasound Destruction of VEGFI-carrying Microbubbles

Experimental Study of Inhibitive Effects of Celecoxib on the Proliferation of Lung Cancer Cells and Angiogenesis

Therapeutic Effects of COX-2 Inhibitor Celecoxib on Nude Mice Bearing Human Pancreatic Cancer Xenograft

The Combined Effects of Celecoxib and Minocycline Hydrochloride on Inhibiting the Osseous Metastasis of Breast Cancer in Nude Mice

Inhibition Effects of Celebrex on the Proliferation of Lewis Lung Cancer Cells and Growth of Transplanted Lewis Lung Carcinoma

Effect of Celecoxib on Growth and Angiogenesis of Orthotopic Transplantation Tumor of Experimental Colorectal Cancer

The Effects of Inhibited the Proliferation by Celecoxib in Human Primary Hepatic Cancer Xenograft of Nude Mice in Vivo

Combined effects of celecoxib and NK Cells on growth of SMMC-7721 hepatocellar carcinoma xenografts in nude mice

Effection of Celecoxib Combined with 5-Fu on Treatmeat of Human Colorectal Cancer in BALB/C Nude Mice Subcutaneous Xenograft Model

Inhibitory Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Angiogenesis in Lung Cancer

Celecoxib Inhibits Tumor Growth and Angiogenesis in an Orthotopic Implantation Tumor Model of Human Colon Cancer.

Effect of Celebrex on the Apoptosis and VEGF Expression of PC12 Cells

In Vivo and in Vitro Studies of Blocking CXC Chemokine Receptor-4 on Bone Metastasis of Breast Cancer

The effect of COX-2 inhibitor on bladder cancer

An animal model of breast carcinoma bone metastasis in vivo